YOUR JOURNEY TO MARKET

Insights and evidence for commercial success

NOTHING COSTS MORE THAN FAILURE: BENEFITS OF EARLY COMMERCIAL STRATEGY

THE RIGHT TOOLS FOR YOUR JOURNEY TO MARKET

EVIDENCE OF VALUE: BUILDING A ROBUST ARGUMENT

A PRAGMATIC APPROACH

FINDING WHAT FITS: CLIENT OVERSIGHT

COMPARATIVE EFFECTIVENESS RESEARCH: ARE WE THERE YET?

INTEGRATED SOLUTIONS

INCREASING THE IMPACT OF OBSERVATIONAL RESEARCH

DEVELOPING A GLOBAL OBSERVATIONAL STUDY

EXPERIENCE MATTERS

STEPPING INTO THE FUTURE

DESIGNING SMARTER TRIALS

BIG SOLUTIONS FOR BIG GLOBAL CHALLENGES

START RIGHT: GETTING THE RIGHT PATIENTS FOR THE RIGHT DATA

IMPLEMENTING AN INVITING INFRASTRUCTURE

WORLDWIDE EFFORTS CALL FOR GROUNDBREAKING IDEAS

MEASURING PERCEPTIONS TO GROW MARKET SHARE

THE KEY TO LATE PHASE SUCCESS

ACCELERATING PATIENT RECRUITMENT

PRICE GLOBALLY: NEGOTIATE LOCALLY

HOW USER-FRIENDLY SOLUTIONS HELP LOWER COSTS

BIG SOLUTIONS FOR BIG GLOBAL CHALLENGES

COMPOUND INTEREST: EVIDENCE-BASED PRIORITIZATION

IDENTIFYING BEST PRACTICES

BUILDING A STURDY GLOBAL VALUE PLATFORM

MARKET ACCESS DATA FUEL: FOR SUCCESSFUL PRODUCT LAUNCHES

DELIVERING DATA: SUPPORTING YOUR COMMERCIAL VALUE EVIDENCE

TODAYS STANDARD GOLD PRODUCT APPROVAL DEMANDS REALWORLD EVIDENCE

DESIGNING TRIALS PAYERS CAN TRUST

COST EFFECTIVENESS MODELING

EARLY ECONOMIC MODELS PAY OFF

PATH TO BETTER TRIAL DESIGN

ONE SIZE DOES NOT FIT ALL

REAL WORLD DATA STRATEGIES

BUILDING VALUE WITH REALWORLD DATA

NEW SCIENCE DEMANDS REALWORLD DATA

PRICE OPTIMIZATION: GLOBAL STRATEGY FOR GLOBAL MARKETS

OPTIONS AND CHALLENGES: BRINGING DRUGS TO MARKET EARLY

BRINGING TALENT TOGETHER

WALKING THE WALK